Multidimensional Evidence Generation and FDA Regulatory Decision Making

This Viewpoint discusses the potential to expand the application of "real-world evidence" from pragmatically designed studies in US Food and Drug Administration regulatory efforts.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vhouc1
via IFTTT